The
following table summarizes the number of potentially dilutive common stock equivalents excluded from the calculation of diluted net loss
per common share as of March 31, 2025 and 2024:
Schedule
of Dilutive Net Loss Per Common Share
| |
| 2025 | | |
| 2024 | |
| (In thousands) | |
March 31, | |
| | |
2025 | | |
2024 | |
| Shares of common stock issuable upon exercise of warrants | |
| 9,837 | | |
| 14,384 | |
| Shares of common stock issuable upon exercise of options | |
| 6,322 | | |
| 5,159 | |
| Potentially dilutive common stock equivalents excluded from diluted net loss per share | |
| 16,159 | | |
| 19,543 | |
|